Research Funding

Since 2005, the Children’s Neuroblastoma Cancer Foundation has funded more than $2 million in neuroblastoma research and programs. The following is an overview of the grants CNCF has provided by fiscal year.

2013-14 Funding
  • Dr. Ting Tao: Dana Farber Cancer Institute - The Role of ARID1A in neuroblastoma tumorigenesis
  • Dr. Bilal Omer:  Baylor College of Medicine - Improving immune cell trafficking to neuroblastoma with “scout cells
2012-13 Funding
  • Dr. Jason Shohet:  Baylor College of Medicine - Analysis of p53 responses and regulation by G-CSFin neuroblastoma cancer stem cell subpopulations.
  • Dr. Julie Park:  Seattle Children’s Hospital - MIBG Scoring Project: COGA3973 and SIOPEN-NBL-1
  • Dr. Sam Volchenboum: Comer Children’s Hospital - “The MYCN Oncogene: Providing Insight to Improved Diagnostic Stratification, Therapeutic Evaluation, and Novel Treatment Design for High-Risk Neuroblastoma."
2011-12 Funding
  • NANT                                                                                                           
  • SIOPEN                                                                                                       
  • Travel grant for MIBG Scoring Project
  • MIBG Scoring Project: COGA3973 and SIOPEN-NBL-1
2009-10 Funding
  • NANT
  • Dr. Susan Cohn, University of Chicago - Interactive International Neuroblastoma Information Network
  • Dr. Susan Cohn, University of Chicago - Genome-wide Analysis of Favorable Stage Neuroblastoma with MYCN Amplification
2008-09 Funding
  • NANT
  • Dr. Nai-Kong Cheung, Memorial Sloan Kettering - Humanized 3F8 Research
  • Dr. Heidi Russell, Texas Children’s Hospital - Pepi Trial
  • Metin Gurcan PhD, Ohio State University - Computer aided prognosis of Neuroblastoma - 2-year grant
  • Dr. Kelly Goldsmith, Children’s Hospital of Philadelphia - Polymine Depletion Strategies in Neuroblastoma - 2-year grant
  • Dr. Eugene Kim, Baylor College of Medicine - The Role of MDM2 in Tumor Angiogenesis in Neuroblastoma - 2-year grant
  • Dr. Hong Xu, Memorial Sloan Kettering - B7H3: An Immunological Target for Neuroblastoma - 2-year grant
  • Dr. Barry Mauerer, Texas Tech University - Purchase of Fenretinide
2007-08 Funding
  • NANT
  • Drs. Seeger/Reynolds, Children’s Hospital LA - Private donation
  • Dr. Susan Cohn, University of Chicago - Genome-wide Analysis of Favorable Stage Neuroblastomas with MYCN Amplification
  • Dr. Cynthia van Golen, Delaware State University - Therapeutic Efficacy of Agents Targeting the IGF-IR in       HumanNeuroblastoma - 2-year grant
  • Dr. Elizabeth Beierle, University of Florida/ University of Alabama, Birmingham - Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor-3 in Neuroblastoma - 2-year grant
  • Dr. Tasnim Ara, Children’s Hospital Los Angeles - Contribution of Bone Marrow Microenvironment to Neuroblastoma Chemoresistance and Tumor Progression - 2-year grant
  • Dr. Alexandre Chlenski, University of Chicago - SPARC-derived peptides for the treatment of Neuroblastoma - 2-year grant
  • Dr. Kristina Cole, Children’s Hospital of Philadelphia - siRNA Inhibition of the Protein Kinome in Neuroblastoma - 2-year grant
2006-07 Funding
  • Dr. Nai-Kong Cheung, Memorial Sloan Kettering
  • Sonia Hernandez, Columbia University - Notch Signaling Pathway and VEGF Blockade in Neuroblastoma - 2-year grant
  • Dr. Jason Shohet, Baylor College of Medicine - MYCN-regulated MicroRNA Expression in Neuroblastoma - 2-year grant
  • Drs. Seeger/Reynolds, Children’s Hospital of Los Angeles - Private donation
2005-06 Funding
  • Dr. Edward Attiyeh, Children’s Hospital of Philadelphia -Genetic basis of aggressive neuroblastoma - 2-year grant
  • Dr. Louis Chesler, University of CA, San Francisco - Proteomic analysis of serum from children with Neuroblastoma - 2-year grant
  • Dr. Radoslaw Zagoadzon, Beth Israel Deaconess - Studies on the role of CHK Kinase on Neuroblastoma - 2-year grant